MUSA is the world’s first surgical robot for open microsurgery. This
robotic assistant is clinically and commercially available after the
medical device CE-mark was issued by notified body DEKRA recently.
Microsure’s MUSA is developed by a team of microsurgeons and engineers,
creating a high-precision robotic assistant that is compatible with
current operating techniques, workflow, instruments and other
OR-equipment. It enhances surgical performance by stabilizing and
scaling down the surgeon’s movements during complex microsurgical
procedures on sub-millimeter scale.
This press release features multimedia. View the full release here:
Surgeons using Microsure’s MUSA during a microsurgical procedure in a patient’s arm. Photo courtesy of Microsure.
Microsure’s MUSA e.g. enables lymphatic surgery on lymph vessels smaller
than 0.3 mm in diameter. Plastic surgeons at Maastricht University
Medical Center+ were the first to use MUSA to surgically treat
lymphedema in a patient. This world’s premier super-microsurgical
intervention with ‘robot hands’ took place in 2017. Maastricht
University Medical Center+ is now conducting several follow up clinical
research projects with MUSA, in different fields of microsurgery. Other
European hospitals are expected to start clinical studies this year.
Microsurgery procedures with MUSA
Surgical procedures that maximally benefit from Microsure’s MUSA are
complex surgeries on small tissue structures –for instance LVA
(Lymphovenous Anastomosis) surgery, pediatric vascalar surgery, free
flap surgery, finger and hand replantation – when human precision is the
limiting factor because of physiological tremor, poor accessibility or
fatigue. Various studies and pilots have proven safe and effective
clinical use of the device.
ISO 13485 certification
Microsure also received the ISO 13485 certificate, another major
milestone. The ISO certification assures that Microsure is adhering to
the highest standards in quality management and regulatory compliance
procedures to develop, manufacture, and test its products and services.
ISO 13485:2016 is the latest update to ISO requirements for a
comprehensive quality management system for the design and manufacture
of medical devices.
Microsure is a medical device company in Eindhoven (The Netherlands)
founded by Eindhoven University of Technology and Maastricht University
Medical Center in 2016, funded by Innovation Industries Fund.
Microsure’s focus is to improve patients’ quality of life through
developing robot systems for microsurgery. Its current product is MUSA,
the world’s first surgical robot for open microsurgery. MUSA has been
designed by microsurgeons and engineers, specifically for microsurgical
applications. MUSA provides superhuman precision for microsurgeons,
enabling new interventions that are currently impossible to perform by